Advanced Robotic Training With Additional Degrees of Freedom: Towards a Free-walking System (LOKOMAT)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02189551 |
Recruitment Status :
Terminated
(an additional intervention, amendet to the study (3rd arm, not described here), has not received clearance by regulatory authorities)
First Posted : July 14, 2014
Last Update Posted : August 15, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The objective of the study is to compare a new medical devices with an established medical device for lower limb rehabilitation regarding training outcome and patient comfort / patient satisfaction (primary objective) and treatment effect (exploratory objective).
Primary study endpoints will be a significantly higher rated patient comfort and or patient satisfaction using the new versions, compared with the established Lokomat. Furthermore, muscle activity and kinematic movement patterns will be expected to show more involved muscle groups and a walking pattern involving more degrees of freedom during use of the new version compared with the established Lokomat.
Exploratory endpoints will be a significantly stronger involvement of muscles needed for balance, more physiological walking patterns and more change on the lateral positioning of the feet due to training with the new version, compared with the established Lokomat.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Post Stroke Gait Training | Behavioral: Gait training with Lokomat Pro Behavioral: Gait training with Lokomat Pro FreeD | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 9 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Health Services Research |
Study Start Date : | June 2014 |
Actual Primary Completion Date : | February 2015 |
Actual Study Completion Date : | February 2015 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Lokomat Pro
gait robot established on the market
|
Behavioral: Gait training with Lokomat Pro |
Experimental: Lokomat Pro FreeD
gait robot based on the Lokomat Pro with changes in guidance of the hip, approved for the Swiss market
|
Behavioral: Gait training with Lokomat Pro FreeD |
- Lateral hip movement [ Time Frame: 30 min training during day 1 (next session after inclusion) ]during 30 min training with each device, lateral hip movements will be assessed
- Patient satisfaction [ Time Frame: day 2 and 3 ]Satisfaction, based on questionnaires, will be assessed after training with the experimental and the standard device in two consecutive sessions (randomized order).
- Patient motivation [ Time Frame: day 2 and 3 ]Patient motivation, based on questionnaires, will be assessed after training with the experimental and the standard device in two consecutive sessions (randomized order).

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Lower extremity weakness due to stroke
- minor functional impairment (MRC < 5)
- ability and willingness to participate
Exclusion Criteria:
- severe spasticity of the lower extremities
- severe dementia
- severe depression
- any other contraindications against Lokomat training
- body weight > 135 kg

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02189551
Switzerland | |
Cereneo, Center For Rehabilitation and Neurology | |
Vitznau, LU, Switzerland, 6354 |
Responsible Party: | Cereneo AG |
ClinicalTrials.gov Identifier: | NCT02189551 |
Other Study ID Numbers: |
EKNZ: 2014-052 |
First Posted: | July 14, 2014 Key Record Dates |
Last Update Posted: | August 15, 2018 |
Last Verified: | August 2018 |